admin

Congratulations to portfolio company Titan IC on its acquisition by Mellanox

Today Mellanox Technologies, Ltd. (NASDAQ: MLNX) has announced that they are acquiring Clarendon Fund Manager’s portfolio company Titan IC.  Titan IC’s world class team in Belfast will become the center of advanced network intelligence research and development for Mellanox. “We are pleased to become part of Mellanox and together we will accelerate the pace of […]

Congratulations to portfolio company Titan IC on its acquisition by Mellanox Read More »

Belfast firm We Are Paradoxx shows off three-in-one Supernova hair gadget

We Are Paradoxx the Clarendon portfolio hair company has unveiled a new cordless three-in-one hair tool. We Are Paradoxx, led by Yolanda Cooper, developed the Supernova appliance, which can straighten, curl and create wavy hairstyles. The company’s products are stocked by retailers around the world, including Harvey Nichols, Saks Fifth Avenue and ASOS. It received

Belfast firm We Are Paradoxx shows off three-in-one Supernova hair gadget Read More »

Belfast health tech firm Neurovalens picked for UK start-up scheme

The Clarendon portfolio Neurovalens behind the headset developed to treat neurological health issues has been chosen for a major UK-wide programme. Neurovalens is one of 30 firms around the UK which has been selected for government body Tech Nation’s Upscale 5.0 programme, which supports fast-growing tech companies. The company’s Modius headset aims to treat neurological

Belfast health tech firm Neurovalens picked for UK start-up scheme Read More »

Fusion Antibodies reports strong revenue growth in third quarter

Clarendon Portfolio company Fusion Antibodies a clinical research firm has reported a strong revenue performance during the third quarter. In a trading update on Wednesday, the publicly listed company said it expects revenues for the year ending March 31 2020 to be significantly ahead of current market expectations, and above the previous year (£2.2 million).

Fusion Antibodies reports strong revenue growth in third quarter Read More »

Cirdan wins Eurofins Pathology cloud-based LIS contract

CLarendon portfolio company Cirdan is delighted to announce the award of a contract by Eurofins Pathology for a new generation Laboratory Information System (LIS). Eurofins Pathology is part of the wider Eurofins Scientific Group, a global leader in life sciences testing, with a presence in 47 countries, providing a unique range of analytical testing services

Cirdan wins Eurofins Pathology cloud-based LIS contract Read More »

Locate a Locum: Belfast firm creates six new jobs with £1m funding

Locate a Locum a Clarendon portfolio firm, which helps locum healthcare professionals find flexible work opportunities, has secured £1m in equity funding that will be used to grow the business and create six new jobs. The company said it uses its “on-demand technology platform to pair thousands of pharmacists around the UK with over 8,000

Locate a Locum: Belfast firm creates six new jobs with £1m funding Read More »

AI pioneer Adoreboard gets funding boost to expand software used by top brands

Clarendon portfolio company Adoreboard has secured funding from the Halo Business Angel Network (HBAN) and Co-Fund II to support a series of major contract wins and create six new jobs. HBAN is a joint initiative of Enterprise Ireland, InterTradeIreland and Invest Northern Ireland, dedicated to the all-island promotion of business angel investment. The Forum allows

AI pioneer Adoreboard gets funding boost to expand software used by top brands Read More »